Target intelligence / Profile preview

Immunoglobulin heavy variable 3-72 (IGHV3-72)

Target
IGHV3-72
Molecular classification
Other (immunoglobulin variable region, antibody component)
01

Overview

Immunoglobulin heavy variable 3-72 (IGHV3-72) is a protein-coding gene that encodes the variable region of the heavy chain of immunoglobulins (antibodies)[1][6][8]. This region forms part of the antigen-binding site of antibodies, which are crucial for the recognition phase of the humoral immune response[1][6]. The variable regions from heavy (e.g., IGHV3-72) and light chains together enable an antibody to bind with high specificity to a particular antigen[1][6][8]. Antigen engagement triggers B cell activation and differentiation into plasma cells that secrete immunoglobulins, mediating antigen clearance[1][8]. IGHV3-72, like other IGHV genes, undergoes genetic recombination and somatic hypermutation to promote antibody diversity. IGHV3-72 is one of many allelic members of the IGHV gene family, contributing to the genetic and functional diversity of the human antibody repertoire[2][4]. Polymorphisms within IGHV genes are linked to differences in immune responses, and certain IGHV alleles/families may be associated with susceptibility or resistance to particular diseases and reactions, although IGHV3-72 itself is not a direct therapeutic target[4]. Diseases possibly associated or studied in connection with IGHV3-72 include toxic pneumonitis and isolated growth hormone deficiency, mainly as part of broader antibody and immune system studies[1]. IGHV3-72 is a genetic element and not a receptor or direct drug target—therapeutic interventions target the antibodies or B cells utilizing this region, not the IGHV3-72 gene specifically[1].

Other names
Immunoglobulin heavy variable 3-72IGHV3-72IGHV372VHimmunoglobulin heavy chain variable region
02

Biological functions

Antigen recognitionImmune responseHumoral immunity
03

Disease associations

CancerInfectionToxic pneumonitisIsolated growth hormone deficiency

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-72 (IGHV3-72).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-72 (IGHV3-72).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call